12-53482632-C-A
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_001193511.2(MAP3K12):c.2171G>T(p.Ser724Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000489 in 1,613,920 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001193511.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
MAP3K12 | NM_001193511.2 | c.2171G>T | p.Ser724Ile | missense_variant | 11/14 | ENST00000547488.6 | NP_001180440.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
MAP3K12 | ENST00000547488.6 | c.2171G>T | p.Ser724Ile | missense_variant | 11/14 | 2 | NM_001193511.2 | ENSP00000449038.1 |
Frequencies
GnomAD3 genomes AF: 0.000243 AC: 37AN: 152236Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000482 AC: 12AN: 248712Hom.: 0 AF XY: 0.0000370 AC XY: 5AN XY: 135116
GnomAD4 exome AF: 0.0000281 AC: 41AN: 1461566Hom.: 0 Cov.: 32 AF XY: 0.0000275 AC XY: 20AN XY: 727064
GnomAD4 genome AF: 0.000249 AC: 38AN: 152354Hom.: 0 Cov.: 32 AF XY: 0.000242 AC XY: 18AN XY: 74488
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Oct 03, 2022 | The c.2171G>T (p.S724I) alteration is located in exon 11 (coding exon 10) of the MAP3K12 gene. This alteration results from a G to T substitution at nucleotide position 2171, causing the serine (S) at amino acid position 724 to be replaced by an isoleucine (I). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at